EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 95 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,036,000 | -8.4% | 914,598 | -9.0% | 0.00% | 0.0% |
| Q2 2022 | $9,867,000 | -1.0% | 1,004,773 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $9,971,000 | +577.8% | 1,015,373 | +573.9% | 0.00% | – |
| Q4 2021 | $1,471,000 | +0.3% | 150,673 | +0.3% | 0.00% | – |
| Q3 2021 | $1,467,000 | +0.4% | 150,173 | 0.0% | 0.00% | – |
| Q2 2021 | $1,461,000 | +50.8% | 150,173 | +51.7% | 0.00% | – |
| Q1 2021 | $969,000 | – | 98,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |